Polymed lines up ₹750 crore for expansion, buys over two years

The company last month raised ₹1,000 crore through qualified institutional placement (QIP) and has ₹150 crore as free cash flow to fund its growth plans. Polymed makes disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets. About two-thirds of sales come from infusion therapy products. The company spends 2% of revenue on R&D.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6mYKvcz
via IFTTT